---
document_datetime: 2023-09-21 19:10:01
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/ebilfumin-epar-all-authorised-presentations_en.pdf
document_name: ebilfumin-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0282488
conversion_datetime: 2025-12-25 07:42:49.854791
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) Number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging     | Pack size   |
|------------------|-------------------|------------|-----------------------|---------------------------|-------------------------|-------------|
| EU/1/14/915/001  | Ebilfumin         | 30 mg      | Capsule, hard         | Oral use                  | blister PVC/PE/PVDC/alu | 10 capsules |
| EU/1/14/915/002  | Ebilfumin         | 30 mg      | Capsule, hard         | Oral use                  | bottle (HDPE)           | 10 capsules |
| EU/1/14/915/003  | Ebilfumin         | 45 mg      | Capsule, hard         | Oral use                  | bottle (HDPE)           | 10 capsules |
| EU/1/14/915/004  | Ebilfumin         | 45 mg      | Capsule, hard         | Oral use                  | blister PVC/PE/PVDC/alu | 10 capsules |
| EU/1/14/915/005  | Ebilfumin         | 75 mg      | Capsule, hard         | Oral use                  | blister PVC/PE/PVDC/alu | 10 capsules |
| EU/1/14/915/006  | Ebilfumin         | 75 mg      | Capsule, hard         | Oral use                  | bottle (HDPE)           | 10 capsules |